Most recently, it's been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in identical places as classical opioid receptors, it binds into a big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts being a scavenger https://andersoni024kfz3.livebloggs.com/profile